Page last updated: 2024-08-24

plerixafor and Non-alcoholic Fatty Liver Disease

plerixafor has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bachelerie, F; Balabanian, K; Bignon, A; Boujedidi, H; Cassard-Doulcier, AM; Emilie, D; Gary-Gouy, H; Hemon, P; Naveau, S; Perlemuter, G; Prévot, S; Renoud, ML; Robert, O; Tharinger, H1

Other Studies

1 other study(ies) available for plerixafor and Non-alcoholic Fatty Liver Disease

ArticleYear
CXCR4 dysfunction in non-alcoholic steatohepatitis in mice and patients.
    Clinical science (London, England : 1979), 2015, Volume: 128, Issue:4

    Topics: Adult; Animals; Benzylamines; CD4-Positive T-Lymphocytes; Cell Movement; Chemokine CXCL12; Cyclams; Disease Models, Animal; Female; Heterocyclic Compounds; Humans; Lymphocyte Count; Male; Mice, Inbred C57BL; Mice, Obese; Middle Aged; Non-alcoholic Fatty Liver Disease; Receptors, CXCR; Receptors, CXCR4; Up-Regulation

2015